KLAC
53
-3
VRTX
55
2
FCX
57
-2
HSIC
60
-2
SO
62
3
EXPE
93
2
GM
65
-7
GRMN
67
-3
GWW
76
2
LEG
43
-7
ROK
64
-2
DUK
64
7
BBY
42
2
DOV
69
2
MPC
44
3
AMZN
59
3
FSLR
46
-3
FOXA
53
3
INTU
56
3
BLK
61
-2
KLAC
53
-3
VRTX
55
2
FCX
57
-2
HSIC
60
-2
SO
62
3
EXPE
93
2
GM
65
-7
GRMN
67
-3
GWW
76
2
LEG
43
-7
ROK
64
-2
DUK
64
7
BBY
42
2
DOV
69
2
MPC
44
3
AMZN
59
3
FSLR
46
-3
FOXA
53
3
INTU
56
3
BLK
61
-2
Financhill
Back

Amplify Weight Loss Drug & Treatment ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
16

THNR
Amplify Weight Loss Drug & Treatment ETF

Last Price:
23.60
Seasonality Move:
--
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
16
Amplify Weight Loss Drug & Treatment ETF (THNR) is a Sell

Is Amplify Weight Loss Drug & Treatment ETF a Buy, Sell or Hold?

  • The current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $23.67. The Score for THNR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • THNR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

THNR Stock Price Chart

What is Amplify Weight Loss Drug & Treatment ETF's stock price today?

  • The Amplify Weight Loss Drug & Treatment ETF share price today is $23.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THNR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

THNR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 35.53 Sell
Chaikin Money Flow: 816 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

THNR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.22 Buy
20-day SMA: 24.23 Sell
50-day SMA: 25.64 Sell
200-day SMA: 0 Buy
8-day EMA: 23.55 Buy
20-day EMA: 24.16 Sell
50-day EMA: 25.19 Sell
200-day EMA: 8.82 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Amplify Weight Loss Drug & Treatment ETF Earnings Growth & THNR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Amplify Weight Loss Drug & Treatment ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):